THC BioMed Intl Ltd. announced that it has appointed Don Shaxon to the company's newly formed Advisory Board. Mr. Shaxon brings 20 years' experience in the capital markets including a successful position as Corporate development Manager with Cannabis Science Inc. where he was instrumental in helping build the company from a small cap company into an industry leader with a market cap that topped $100 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 CAD | -.--% | -.--% | -.--% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.4M | |
+42.07% | 6.23B | |
+5.38% | 3.32B | |
-16.98% | 2.91B | |
-5.82% | 2.42B | |
+45.47% | 1.94B | |
-12.67% | 1.59B | |
-3.91% | 1.58B | |
+44.56% | 1.49B | |
-15.57% | 1.48B |
- Stock Market
- Equities
- THC Stock
- News THC Biomed Intl Ltd.
- THC BioMed Intl Ltd. Appoints Don Shaxon to its Advisory Board